- Home
- SRPT vs HALO Comparison
SRPT vs HALO Comparison
Compare SRPT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- HALO
- Stock Information
- Founded
- SRPT 1980
- HALO 1998
- Country
- SRPT United States
- HALO United States
- Employees
- SRPT N/A
- HALO N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRPT Health Care
- HALO Health Care
- Exchange
- SRPT Nasdaq
- HALO Nasdaq
- Market Cap
- SRPT 9.8B
- HALO 8.0B
- IPO Year
- SRPT 1997
- HALO N/A
- Fundamental
- Price
- SRPT $70.41
- HALO $63.84
- Analyst Decision
- SRPT Buy
- HALO Buy
- Analyst Count
- SRPT 21
- HALO 9
- Target Price
- SRPT $164.05
- HALO $61.63
- AVG Volume (30 Days)
- SRPT 2.2M
- HALO 1.6M
- Earning Date
- SRPT 04-30-2025
- HALO 05-06-2025
- Dividend Yield
- SRPT N/A
- HALO N/A
- EPS Growth
- SRPT N/A
- HALO 63.33
- EPS
- SRPT 2.34
- HALO 3.43
- Revenue
- SRPT $1,901,979,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- SRPT $67.83
- HALO $20.06
- Revenue Next Year
- SRPT $25.66
- HALO $23.87
- P/E Ratio
- SRPT $30.11
- HALO $18.61
- Revenue Growth
- SRPT 52.97
- HALO 22.44
- 52 Week Low
- SRPT $69.82
- HALO $37.73
- 52 Week High
- SRPT $173.25
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- SRPT 27.35
- HALO 62.51
- Support Level
- SRPT $70.91
- HALO $63.21
- Resistance Level
- SRPT $76.67
- HALO $66.00
- Average True Range (ATR)
- SRPT 4.14
- HALO 1.69
- MACD
- SRPT -1.57
- HALO -0.03
- Stochastic Oscillator
- SRPT 1.78
- HALO 61.57
Stock Price Comparison Chart: SRPT vs HALO
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.